DSpace at RU >

Search Results

Results 1-14 of 14.

Item hits:

Full Text	Issue Date	Title	Author(s)
	2011	Adherence to HIV therapeutic drug monitoring guidelines in The Netherlands	Luin, M. van; Wit, F.W.; Smit, C.; Rigter, I.M.; Franssen, E.J.; Richter, C.; Kroon, F.; Wolf, F. de; Burger, D.M.
	2010	HIV treatment: A clinical pharmacology perspective.	Luin, M. van
	2010	No changes in efavirenz plasma concentrations in HIV-infected patients who switch from Stocrin to Atripla.	Burger, D.M.; Luin, M. van; Bosch, M.; Ven, A.J.A.M. van der; Brouwer, A.M.; Keuter, M.; Dofferhoff, T.; Koopmans, P.P.
	2010	Effect of posaconazole on the pharmacokinetics of fosamprenavir and vice versa in healthy volunteers.	Bruggemann, R.J.M.; Luin, M. van; Colbers, E.P.H.; Dungen, M.W. van den; Pharo, C.; Schouwenberg, B.J.J.W.; Burger, D.M.
	2010	Lower atovaquone/proguanil concentrations in patients taking efavirenz, lopinavir/ritonavir or atazanavir/ritonavir.	Luin, M. van; Ende, M.E. van der; Richter, C.; Visser, M. de; Faraj, D.; Ven, A.J.A.M. van der; Gelinck, L.; Kroon, F.; Wit, F.W.; Schaik, R.H. van; Kuks, P.F.M.; Burger, D.M.
	2010	Drug-drug interactions between raltegravir and pravastatin in healthy volunteers.	Luin, M. van; Colbers, A.; Ewijk-Beneken Kolmer, E.W.J. van; Verwey-van Wissen, C.P.W.G.M.; Schouwenberg, B.J.J.W.; Hoitsma, A.J.; Silva, H.G. da; Burger, D.M.
	2009	Efavirenz Dose Reduction Is Safe in Patients With High Plasma Concentrations and May Prevent Efavirenz Discontinuations	Luin, M. van; Gras, L.; Richter, C.; Ende, M.E. van der; Prins, J.M.; Wolf, F. de; Burger, D.M.; Wit, F.W.
	2009	Efavirenz dose reduction to 200 mg once daily in a patient treated with rifampicin.	Luin, M. van; Brouwer, A.E.; Ven, A.J.A.M. van der; Lange, W. de; Schaik, R.H. van; Burger, D.M.
	2009	The effect of raltegravir on the glucuronidation of lamotrigine.	Luin, M. van; Colbers, A.; Verwey-van Wissen, C.P.W.G.M.; Ewijk-Beneken Kolmer, E.W.J. van; Kolk, M. van der; Hoitsma, A.J.; Silva, H.G. da; Burger, D.M.
	2009	Absence of a relation between efavirenz plasma concentrations and toxicity-driven efavirenz discontinuations in the EuroSIDA study.	Luin, M. van; Bannister, W.P.; Mocroft, A.; Reiss, P.; Perri, G. Di; Peytavin, G.; Molto, J.; Karlson, A.; Castagna, A.; Beniowski, M.; Lundgren, J.D.; Burger, D.M.
	2008	Toxische epidermale necrolyse bij een hiv-geinfecteerde patient	Majoor, C.J.; Luin, M. van; Maessen-Visch, M.B.; Langebeek, N.; Richter, C.
	2008	Use of therapeutic drug monitoring in HIV disease	Luin, M. van; Kuks, P.F.M.; Burger, D.M.
	2008	[Acute caffeine intoxication after intake of 'herbal energy capsules']	Kromhout, H.E.; Landstra, A.M.; Luin, M. van; Setten, P.A. van
	2008	Reality of severe metformin-induced lactic acidosis in the absence of chronic renal impairment.	Bruijstens, L.A.; Luin, M. van; Buscher-Jungerhans, P.M.; Bosch, F.H.

1